+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Live Attenuated Vaccine"

From
From
From
From
From
From
H1N1 Vaccine Market Report 2025 - Product Thumbnail Image

H1N1 Vaccine Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Pediatric Vaccine Market Opportunities and Strategies to 2033 - Product Thumbnail Image

Pediatric Vaccine Market Opportunities and Strategies to 2033

  • Report
  • January 2025
  • 286 Pages
  • Global
From
Edible Vaccine Market Report 2024 - Product Thumbnail Image

Edible Vaccine Market Report 2024

  • Report
  • December 2024
  • 175 Pages
  • Global
From
Dengue Vaccine Market Report 2024 - Product Thumbnail Image

Dengue Vaccine Market Report 2024

  • Report
  • December 2024
  • 175 Pages
  • Global
From
Sheep And Goat Pox Vaccines Global Market Report 2024 - Product Thumbnail Image

Sheep And Goat Pox Vaccines Global Market Report 2024

  • Report
  • August 2024
  • 175 Pages
  • Global
From
Loading Indicator

Live attenuated vaccines are a type of vaccine that use a weakened form of a virus or bacteria to stimulate an immune response. These vaccines are designed to replicate the natural infection process, allowing the body to develop immunity without the risk of serious illness. Live attenuated vaccines are typically administered orally or nasally, and are often used to protect against diseases such as measles, mumps, rubella, and rotavirus. Live attenuated vaccines are generally considered to be safe and effective, and are often used in combination with other vaccines to provide broader protection. They are also cost-effective, as they require fewer doses than other types of vaccines. Notable companies in the live attenuated vaccine market include Merck & Co., GlaxoSmithKline, Sanofi Pasteur, Pfizer, and Novartis. Show Less Read more